⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL7937798 | 0.89 | — | — | |
| SCHEMBL12316037 | 0.78 | — | — | |
| SCHEMBL19634343 | 0.75 | MEN1 (0.31) | — | |
| SCHEMBL19376915 | 0.75 | MEN1 (0.31) | — | |
| SCHEMBL10724194 | 0.75 | — | — | |
| SCHEMBL1235474 | 0.71 | — | — | |
| SCHEMBL978834 | 0.71 | — | — | |
| SCHEMBL3702182 | 0.71 | — | — | |
| SCHEMBL12519254 | 0.71 | CA12 (0.56) | — | |
| SCHEMBL308579 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118299525-A | Negative electrode active material, preparation method and application | 宁德时代新能源科技股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-112067596-B | In-situ analysis method for crystal transformation rate of HNIW crystal form in propellant powder | 西安近代化学研究所 | 2024-05-10 | — | — | CN | claimed |
| CN-118299525-A | Negative electrode active material, preparation method and application | 宁德时代新能源科技股份有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-117285789-A | Modified polypropylene material and preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| WO-2023192228-A1 | ELECTROCATALYTIC CONVERSION OF NITRATES AND NITRITES TO AMMONIA | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20230174459-A1 | LIPID CONTAINING FORMULATIONS | ARBUTUS BIOPHARMA CORPORATION (US) | 2023-06-08 | — | — | US | disclosed |
| EP-3277286-B1 | BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARM INC (US) | 2021-04-21 | — | — | EP | disclosed |
| CN-110964223-A | Application of amine compound with reversible protection of carbon dioxide | 中国科学院长春应用化学研究所 | 2020-04-07 | — | — | CN | disclosed |
| WO-2020057047-A1 | CARBON DIOXIDE REVERSIBLY PROTECTED CHAIN-EXTENDING CROSS-LINKING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院长春应用化学研究所 | 2020-03-26 | — | — | WO | disclosed |
| CN-109280144-A | The chain extension-crosslinking agent and the preparation method and application thereof of the reversible protection of carbon dioxide | 中国科学院长春应用化学研究所 | 2019-01-29 | — | — | CN | disclosed |
| US-20180188235-A1 | METHODS FOR IDENTIFYING ARTHROPOD REPELLENTS AND ATTRACTANTS, AND COMPOUNDS AND COMPOSITIONS IDENTIFIED BY SUCH METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-07-05 | — | — | US | disclosed |
| US-20070049593-A1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| EP-1719773-A1 | FUSED HETEROTETRACYCLIC COMPOUNDS AND USE TEHREOF AS HCV POLYMERASE INHIBITOR | Japan Tobacco, Inc. (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1688420-A1 | 5-5-MEMBERED FUSED HETEROCYCLIC COMPOUND AND USE THEREOF AS HCV POLYMERASE INHIBITOR | JAPAN TOBACCO INC. (JP) | 2006-08-09 | — | — | EP | disclosed |
| US-20060167246-A1 | Thienopyrrole compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1051415-B1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-6495542-B1 | SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-1051415-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999037637-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-07-29 | — | — | WO | disclosed |
| EP-0228192-A2 | Renin-inhibitory oligopeptides, their preparation and use | SANKYO COMPANY LIMITED (JP) | 1987-07-08 | — | — | EP | disclosed |